Focus of the Week

May 07, 2020
A study published this week found that germline testing of pediatric and young adult patients with cancer demonstrates that some tumors have actionable genetic variants.
May 06, 2020
Lupin Pharmaceuticals Inc. (Lupin) announced positive results from its phase 3 trial assessing the efficacy and safety of secnidazole (Solosec) in female patients with trichomoniasis. Although trichomoniasis is common in the United States, the risk of being infected with the infection is nearly 10 times higher for African American women compared with non-Hispanic white women.
May 05, 2020
As the coronavirus disease 2019 pandemic causes employers nationwide to implement strategies to efficiently operate amid potential revenue loss, the National Alliance of Healthcare Purchaser Coalitions released a comprehensive plan for employers and plan sponsors to optimize the delivery of advanced primary care.
May 04, 2020
The CDC recommends regular testing for bacterial sexually transmitted diseases (STDs) among all sexually active gay, bisexual, and other men who have sex with men (MSM). Chief among these STDs are gonorrhea, chlamydia, syphilis, and hepatitis C.
April 30, 2020
Overall, biosimilar rituximab was used in more than 50% of patients, both as first-line therapy, second line or later.
April 29, 2020
In an opinion article published in JAMA Neurology, researchers discuss how the coronavirus disease 2019 (COVID-19) pandemic has transformed neurologic care more than any other crisis in modern history.
April 28, 2020
A new Gallup poll found that 1 of 7 Americans (14%) reported they would avoid seeking healthcare for a fever and dry cough—common symptoms of the coronavirus disease 2019 (COVID-19)—for themselves or a family member due to cost concerns. Totaled, this percentage amounts to millions of Americans.
April 27, 2020
According to the most recent PwC Health Research Institute Consumer Survey results, the top consumer concerns for the post–coronavirus disease 2019 (COVID-19) period are overall health and financial well-being, with 32% saying health-related spending adjustments have already occurred or are in the planning stages.
April 24, 2020
Chimeric antigen receptor (CAR) T-cell therapy has been shown to improve health-related quality of life in patients with relapsed/refractory diffuse large B-cell lymphoma (LBCL). Currently, CAR T-cell therapies are primarily administered in inpatient settings. In a study published in JAMA Network Open, researchers found CAR T-cell therapy administered to patients with relapsed or refractory LBCL in outpatient settings was associated with lower estimated overall costs.
April 22, 2020
As some states move to eschew social distancing recommendations by beginning plans to reopen businesses amid the coronavirus disease 2019 pandemic, a group of economists highlight in a recent study that the potential benefits of social distancing in saving lives far outweigh the projected damage to the economy.
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.